Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response

被引：15

作者：

Breccia, Massimo ^{[1
]}

Loglisci, Giuseppina ^{[1
]}

Cannella, Laura ^{[1
]}

Finsinger, Paola ^{[1
]}

Mancini, Marco ^{[1
]}

Serrao, Alessandra ^{[1
]}

Santopietro, Michelina ^{[1
]}

Salaroli, Adriano ^{[1
]}

Alimena, Giuliana ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy

来源：

LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 05期

关键词：

AZACITIDINE;

D O I：

10.3109/10428194.2011.643408

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：985 / 986

页数：2

共 5 条

[1] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].

Cheson, Bruce D. ;

Greenberg, Peter L. ;

Bennett, John M. ;

Lowenberg, Bob ;

Wijermans, Pierre W. ;

Nimer, Stephen D. ;

Pinto, Antonio ;

Beran, Miloslav ;

de Witte, Theo M. ;

Stone, Richard M. ;

Mittelman, Moshe ;

Sanz, Guillermo F. ;

Gore, Steven D. ;

Schiffer, Charles A. ;

Kantarjian, Hagop .

BLOOD, 2006, 108 (02) :419-425

[2] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Finelli, Carlo ;

Giagounidis, Aristoteles ;

Schoch, Robert ;

Gattermann, Norbert ;

Sanz, Guillermo ;

List, Alan ;

Gore, Steven D. ;

Seymour, John F. ;

Bennett, John M. ;

Byrd, John ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

LANCET ONCOLOGY, 2009, 10 (03) :223-232

[3] Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine [J].

Itzykson, Raphael ;

Thepot, Sylvain ;

Quesnel, Bruno ;

Dreyfus, Francois ;

Beyne-Rauzy, Odile ;

Turlure, Pascal ;

Vey, Norbert ;

Recher, Christian ;

Dartigeas, Caroline ;

Legros, Laurence ;

Delaunay, Jacques ;

Salanoubat, Celia ;

Visanica, Sorin ;

Stamatoullas, Aspasia ;

Isnard, Francoise ;

Marfaing-Koka, Anne ;

de Botton, Stephane ;

Chelghoum, Youcef ;

Taksin, Anne-Laure ;

Plantier, Isabelle ;

Ame, Shanti ;

Boehrer, Simone ;

Gardin, Claude ;

Beach, C. L. ;

Ades, Lionel ;

Fenaux, Pierre .

BLOOD, 2011, 117 (02) :403-411

[4] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B [J].

Silverman, LR ;

Demakos, EP ;

Peterson, BL ;

Kornblith, AB ;

Holland, JC ;

Odchimar-Reissig, R ;

Stone, RM ;

Nelson, D ;

Powell, BL ;

DeCastro, CM ;

Ellerton, J ;

Larson, RA ;

Schiffer, CA ;

Holland, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2429-2440

[5] The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes [J].

Vardiman, James W. ;

Thiele, Juergen ;

Arber, Daniel A. ;

Brunning, Richard D. ;

Borowitz, Michael J. ;

Porwit, Anna ;

Harris, Nancy Lee ;

Le Beau, Michelle M. ;

Hellstrom-Lindberg, Eva ;

Tefferi, Ayalew ;

Bloomfield, Clara D. .

BLOOD, 2009, 114 (05) :937-951

← 1 →